Melnick R - Search Results

1

Human consumption of methyleugenol and its elimination from serum.

Schecter A, Lucier GW, Cunningham ML, Abdo KM, Blumenthal G, Silver AG, Melnick R, Portier C, Barr DB, Barr JR, Stanfill SB, Patterson DG Jr, Needham LL, Stopford W, Masten S, Mignogna J, Tung KC. Schecter A, et al. Among authors: melnick r. Environ Health Perspect. 2004 May;112(6):678-80. doi: 10.1289/ehp.6766. Environ Health Perspect. 2004. PMID: 15121510 Free PMC article. Clinical Trial.

2

Hexavalent chromium is carcinogenic to F344/N rats and B6C3F1 mice after chronic oral exposure.

Stout MD, Herbert RA, Kissling GE, Collins BJ, Travlos GS, Witt KL, Melnick RL, Abdo KM, Malarkey DE, Hooth MJ. Stout MD, et al. Environ Health Perspect. 2009 May;117(5):716-22. doi: 10.1289/ehp.0800208. Epub 2008 Dec 31. Environ Health Perspect. 2009. PMID: 19479012 Free PMC article.

3

Cell proliferation and chemical carcinogenesis: symposium overview.

Melnick RL, Huff J, Barrett JC, Maronpot RR, Lucier G, Portier CJ. Melnick RL, et al. Environ Health Perspect. 1993 Dec;101 Suppl 5(Suppl 5):3-7. doi: 10.1289/ehp.93101s53. Environ Health Perspect. 1993. PMID: 7912189 Free PMC article. Review.

4

Implications for risk assessment of suggested nongenotoxic mechanisms of chemical carcinogenesis.

Melnick RL, Kohn MC, Portier CJ. Melnick RL, et al. Environ Health Perspect. 1996 Mar;104 Suppl 1(Suppl 1):123-34. doi: 10.1289/ehp.96104s1123. Environ Health Perspect. 1996. PMID: 8722116 Free PMC article. Review.

5

Summary of the National Toxicology Program's report of the endocrine disruptors low-dose peer review.

Melnick R, Lucier G, Wolfe M, Hall R, Stancel G, Prins G, Gallo M, Reuhl K, Ho SM, Brown T, Moore J, Leakey J, Haseman J, Kohn M. Melnick R, et al. Environ Health Perspect. 2002 Apr;110(4):427-31. doi: 10.1289/ehp.02110427. Environ Health Perspect. 2002. PMID: 11940462 Free PMC article. Review.

6

Pharmacokinetics of sodium nitrite-induced methemoglobinemia in the rat.

Kohn MC, Melnick RL, Ye F, Portier CJ. Kohn MC, et al. Drug Metab Dispos. 2002 Jun;30(6):676-83. doi: 10.1124/dmd.30.6.676. Drug Metab Dispos. 2002. PMID: 12019195

7

The U.S. federal framework for research on endocrine disruptors and an analysis of research programs supported during fiscal year 1996.

Reiter LW, DeRosa C, Kavlock RJ, Lucier G, Mac MJ, Melillo J, Melnick RL, Sinks T, Walton BT. Reiter LW, et al. Among authors: melnick rl. Environ Health Perspect. 1998 Mar;106(3):105-13. doi: 10.1289/ehp.98106105. Environ Health Perspect. 1998. PMID: 9443998 Free PMC article.

8

A physiologically based pharmacokinetic model for inhalation and intravenous administration of naphthalene in rats and mice.

Willems BA, Melnick RL, Kohn MC, Portier CJ. Willems BA, et al. Among authors: melnick rl. Toxicol Appl Pharmacol. 2001 Oct 15;176(2):81-91. doi: 10.1006/taap.2001.9269. Toxicol Appl Pharmacol. 2001. PMID: 11601884

9

Exposure to hexavalent chromium resulted in significantly higher tissue chromium burden compared with trivalent chromium following similar oral doses to male F344/N rats and female B6C3F1 mice.

Collins BJ, Stout MD, Levine KE, Kissling GE, Melnick RL, Fennell TR, Walden R, Abdo K, Pritchard JB, Fernando RA, Burka LT, Hooth MJ. Collins BJ, et al. Among authors: melnick rl. Toxicol Sci. 2010 Dec;118(2):368-79. doi: 10.1093/toxsci/kfq263. Epub 2010 Sep 15. Toxicol Sci. 2010. PMID: 20843897 Free PMC article.

10

Cell proliferation and chemical carcinogenesis: a symposium overview.

Melnick RL, Huff J, Barrett JC, Maronpot RR, Lucier G, Portier CJ. Melnick RL, et al. Mol Carcinog. 1993;7(3):135-8. doi: 10.1002/mc.2940070302. Mol Carcinog. 1993. PMID: 8489710 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

158 results

Search Page